SEPN
Price:
$26.16
Market Cap:
$1.17B
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products candidates for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. The company develops SEP-786, an oral small molecule PTH1R agonist for hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 NAM for chronic spontaneous urticaria and other mast cell diseases; TSHR Program, an oral small molecule TSHR NAM for Graves' disease and thyroid eye disease. It also develops oral small molecule single- and multi-incretin receptor agonists for metabolic disorders including obesity and type 2 diabetes. Septerna, Inc. was form...[Read more]
Industry
Biotechnology
IPO Date
2024-10-25
Stock Exchange
NASDAQ
Ticker
SEPN
According to Septerna, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.79. This represents a change of -270.65% compared to the average of 2.22 of the last 4 quarters.
The mean historical PE Ratio of Septerna, Inc. over the last ten years is 27.19. The current -3.79 PE Ratio has changed -1493.70% with respect to the historical average. Over the past ten years (40 quarters), SEPN's PE Ratio was at its highest in in the September 2025 quarter at 25.51. The PE Ratio was at its lowest in in the March 2024 quarter at -15.86.
Average
27.19
Median
-3.15
Minimum
-15.07
Maximum
99.81
Discovering the peaks and valleys of Septerna, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = 99.81
Minimum Annual Increase = -762.11%
Minimum Annual PE Ratio = -15.07
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -3.15 | -103.16% |
| 2023 | 99.81 | -762.11% |
The current PE Ratio of Septerna, Inc. (SEPN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
27.19
5-year avg
27.19
10-year avg
27.19
Septerna, Inc.’s PE Ratio is greater than Bicara Therapeutics Inc. Common Stock (-9.97), greater than Tango Therapeutics, Inc. (-7.52), less than Fortrea Holdings Inc. (-1.30), less than Prime Medicine, Inc. (-3.13), greater than Kura Oncology, Inc. (-4.84), greater than EyePoint Pharmaceuticals, Inc. (-5.70), greater than ProKidney Corp. (-4.64), greater than Maravai LifeSciences Holdings, Inc. (-4.42), greater than Nurix Therapeutics, Inc. (-6.20), greater than Arbutus Biopharma Corporation (-20.00),
| Company | PE Ratio | Market cap |
|---|---|---|
| -9.97 | $1.03B | |
| -7.52 | $1.09B | |
| -1.30 | $1.31B | |
| -3.13 | $681.46M | |
| -4.84 | $1.04B | |
| -5.70 | $1.15B | |
| -4.64 | $723.22M | |
| -4.42 | $1.02B | |
| -6.20 | $1.39B | |
| -20.00 | $847.53M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Septerna, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Septerna, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Septerna, Inc.'s PE Ratio?
How is the PE Ratio calculated for Septerna, Inc. (SEPN)?
What is the highest PE Ratio for Septerna, Inc. (SEPN)?
What is the 3-year average PE Ratio for Septerna, Inc. (SEPN)?
What is the 5-year average PE Ratio for Septerna, Inc. (SEPN)?
How does the current PE Ratio for Septerna, Inc. (SEPN) compare to its historical average?